BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 2.400
0.00 (0.00%)
Jul 31, 2025, 5:24 PM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 58.83 million as of August 1, 2025. Its market cap has decreased by -71.64% in one year.
Market Cap
58.83M
Enterprise Value
11.81M
Revenue
83.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.40
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 58.83M, an increase of 35,983.46%. That is a compound annual growth rate of 37.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 58.83M | -31.24% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | 192.39M | 108.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 65.21B |
| Danel (Adir Yeoshua) | 2.78B |
| Kamada | 1.47B |
| Bait Bakfar | 1.13B |
| SofWave Medical | 879.72M |
| BrainsWay | 756.69M |
| Novolog (Pharm-Up 1966) | 710.12M |
| Ilex Medical | 675.20M |